Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.46 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | MDM4 | O15151 | 1/20 | 0.46 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1856571 | 0.84 | MDM4 (0.62) | ALDH1A1NPSR1MDM4MDM2TSHR | |
| SCHEMBL4152603 | 0.84 | MDM4 (0.62) | ALDH1A1NPSR1MDM4MDM2TSHR | |
| SCHEMBL4153061 | 0.80 | MDM4 (0.67) | ALDH1A1NPSR1MDM4MDM2TSHR | |
| SCHEMBL4149824 | 0.80 | MDM4 (0.67) | ALDH1A1NPSR1MDM4MDM2TSHR | |
| SCHEMBL4149820 | 0.80 | MDM4 (0.67) | ALDH1A1NPSR1MDM4MDM2TSHR | |
| SCHEMBL4153058 | 0.80 | MDM4 (0.67) | ALDH1A1NPSR1MDM4MDM2TSHR | |
| SCHEMBL5381881 | 0.79 | ALDH1A1 (0.54) | ALDH1A1HDAC2HDAC8ESR1ESR2 | |
| SCHEMBL5370183 | 0.79 | L3MBTL1 (0.56) | ALDH1A1TAS1R3TAS1R1KMT2A | |
| SCHEMBL5371472 | 0.77 | TAS1R3 (0.52) | ALDH1A1TAS1R3TAS1R1 | |
| SCHEMBL13602582 | 0.76 | ALDH1A1 (0.69) | ALDH1A1HDAC2HDAC8TSHRESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7223793-B2 | Phenolic acid derivatives and composition for preventing or treating blood lipid level-related diseases comprising the same | BIONUTRIGEN CO., LTD. (KR) | 2007-05-29 | — | — | US | disclosed |
| US-20030199566-A1 | Phenolic acid derivatives and composition for preventing or treating blood lipid level-related diseases comprising the same | BIONUTRIGEN CO., LTD. (KR) | 2003-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030199566-A1 | Phenolic acid derivatives and composition for preventing or treating blood lipid level-related diseases comprising the same | NCEH1, HMGCR, DBH | ALDH1A1 498/4885TAS1R3 1647/4885TAS1R1 1429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.